News & Analysis on Clinical Trial Services & Contract Research And Development
The threat of antibiotic resistance reared its ugly head again after US researchers found that the most common antibiotic treatments do not work in a significant number of cases, leading for calls to find viable alternatives to ageing, established,...
Oman Pharmaceutical Products (OPP) has entered its first outsourcing partnership in Europe with Finnish company Dragenopharm, providing the first step in its strategy to offer contract manufacturing services globally.
A recent study highlights the importance of a new a target for taste modulation that could be the key to helping drug manufacturers mask bitter, unwanted tastes that turn many people off their medicines.
A group of researchers think they have cracked the gene code behind a key family of fungi, which includes the leading cause of death in leukaemia and bone marrow transplant patients. The genome discovery could help combat disease and lead to new drugs.
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
PDI, who provides sales and marketing services to the pharmaceutical industry, have received a new sales representative contract in the US from GlaxoSmithKline (GSK), worth $65-70m (€55-59m).